| Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024. | |
| | |
MedLine Citation:
|
PMID: 23387899 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Human carbonic anhydrase (hCA) IX is involved in tumorigenesis and metastasis through pathways modulating extracellular pH regulation and cell adhesion control. As a consequence, hCA IX represents a promising antitumor target for the development of new drugs in order to treat/image hypoxic cancers, and different agents targeting hCA IX are currently in Phase I - III clinical trials. Among novel chemotypes, coumarins and their congeners were shown to be potent and selective hCA IX inhibitors (CAI) in vitro with an alternative mechanism of action in respect to sulfonamide-based inhibitors. Furthermore, treatment of mice harboring CA IX-positive 4T1 mammary tumors with these selective coumarin-based CA IX inhibitors resulted in significant reduction of tumor growth and metastasis formation in both spontaneous and experimental models of metastasis. |
| | |
Authors:
|
Simone Carradori |
Related Documents
:
|
23125139 - Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic ir... 12036969 - An in vitro assay to assess uveal melanoma invasion across endothelial and basement mem... 16680569 - Matrix metalloproteinases and tumor metastasis. 9180929 - Metastatic ability of mxt mouse mammary subpopulations correlates with clonal expressio... 14657599 - Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. 8995219 - Stimulation of matrix metalloproteinase production by recombinant extracellular matrix ... 23464969 - Mixed adenoneuroendocrine carcinoma of the gallbladder with squamous cell carcinomatous... 10403559 - Antitumor activity of four macrocyclic ellagitannins from cuphea hyssopifolia. 6204739 - Antikeratin antibodies in tumor diagnosis. distinction between seminoma and embryonal c... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-2-7 |
Journal Detail:
|
Title: Expert opinion on therapeutic patents Volume: - ISSN: 1744-7674 ISO Abbreviation: Expert Opin Ther Pat Publication Date: 2013 Feb |
Date Detail:
|
Created Date: 2013-2-7 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9516419 Medline TA: Expert Opin Ther Pat Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Sapienza University of Rome, Department of Drug Chemistry and Technologies , P.le A. Moro 5, 00185 Rome , Italy +0039 06 4969 3242 ; +0039 06 4969 3923 ; simone.carradori@uniroma1.it. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Optimum cooking conditions for shrimp and atlantic salmon.
Next Document: Evidence-Based Practice Process Quality Assessment: EPQA Guidelines.